Gene mutation with a role in cardiomyopathy identified
Our cells demand peak performance. Usually when proteins wear out, or suffer damage, they’re broken up and their parts reused. This vital recycling keeps demanding tissues like muscles working efficiently. Compared to the slice of healthy mouse’s heart on the left, disruption to recycling leaves the second mouse’s heart strewn with clumped-together chemicals (highlighted in red on the right). Mutation in a single gene, BAG3, allows harmful 'junk' proteins to build up – the heart gradually becomes less efficient; eventually its cells will die. While such mutations are rare, human sufferers often develop severe childhood cardiomyopathy and rarely live beyond 20 years of age. As with many rare conditions, research funding is often focussed elsewhere, but here a team of scientists explores potential treatments, including gene therapies, that might one day help with other rare disorders.
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.